Tirzepatide is one step closer to being approved for weight loss
Many of our patients at DETS already know about Tirzepatide and the benefit it has on their Type 2 Diabetes. It is also gaining spotlight attention for its impressive weight loss results too. Eli Lilly has been running clinical trials and on April 27th, released the findings from their phase 3 clinical trial called SURMOUNT-2. Here is a link to that news release and to read about the current findings.
Exciting Findings
The exciting news is that Tirzepatide seems to show an average weight loss of around 35 pounds compared to 7 pounds in the placebo group over a 72-week period.
The consensus is that it will likely receive US FDA approval for weight loss sometime this year and will become one of the leaders in medical weight loss therapies in addition to diabetes control.
In the fall of 2022, when our office was gearing up for the start of ReSet, our Metabolic weight loss program, I learned that once FDA approval for a drug has been achieved for a medication already approved but for a different reason, the brand name of the drug will need to change as well.
An example of this would be Ozempic and Wegovy. Both are Semaglutides from the same manufacturer, Novo Nordisk, and essentially the same medication but the dosages vary based on the purpose of the medication.
It will not be a surprise then when Tirzepatide is approved for weight loss, that the brand name will be called something other than Mounjaro.
HOW CAN OUR OFFICE HELP?
In our ReSet program, we currently offer Semaglutide Plus and Tirzepatide Plus, which we receive from a vetted, local compounding pharmacy in conjunction with a team of specialists (Endocrinologists, Medical Providers, Nutritionists, and Dieticians) to provide an individualized plan specific to your weight loss needs and based on several health factors that we analyze regularly while in the program.
ReSet is currently offered to existing patients and those interested in losing weight that meets criteria such as BMI 28 or over, having over 30 pounds of weight to lose, having elevated A1c levels, and other high-risk factors. If you do not live in Utah, check with our office to see if you can still be seen via telehealth.
At Diabetes & Endocrine Treatment Specialists (DETS) we strive to provide the best care for our patients that have Diabetes, Pre-Diabetes, and Thyroid issues. If you would like a consult with one of the providers in our clinic &/or to learn more about our ReSet program, please give us a call.
